Home > Financial Ratios > SHREE GANESH REMEDIES

SHREE GANESH REMEDIES
EV/Core EBITDA

    Back to All Ratios
SHREE GANESH REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SHREE GANESH REMEDIES
Please provide your vote to see the results

SHREE GANESH REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2020Mar2019
   EV/Core EBITDA(x) 21.9219.544.094.88

What is the latest EV/Core EBITDA ratio of SHREE GANESH REMEDIES ?

The latest EV/Core EBITDA ratio of SHREE GANESH REMEDIES is 21.92 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202521.92
Mar202419.54
Mar20204.09
Mar20194.88

How is EV/Core EBITDA of SHREE GANESH REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2025 21.92
12.18
Mar2024 19.54
377.75
Mar2020 4.09
-16.19
Mar2019 4.88 -

Other Financial Ratios of SHREE GANESH REMEDIES


Compare EV/Core EBITDA ratio of peers of SHREE GANESH REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES ₹768.6 Cr -7.4% 19.2% -4.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,620.0 Cr 1% -0.9% 6.8% Stock Analytics
DIVIS LABORATORIES ₹176,087.0 Cr 1.8% -2.3% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹154,837.0 Cr 3.7% 6.5% 44.9% Stock Analytics
CIPLA ₹112,194.0 Cr 0% 4.7% -8% Stock Analytics
DR REDDYS LABORATORIES ₹106,328.0 Cr -0.2% 0.7% -3.4% Stock Analytics


SHREE GANESH REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES

-7.4%

19.2%

-4.3%

SENSEX

1.7%

1.3%

-7.3%


You may also like the below Video Courses